SEC Form 4 · accession 0001209191-15-027293
EAGLE PHARMACEUTICALS, INC. · EGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven B Ratoff
Director
Period of report
Mar 13, 2015
Accepted (ET)
Mar 17, 2015 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $46.09 | Mar 13, 2015 | A | 5,000 | A | — | Mar 12, 2025 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1The option fully vests on March 13, 2016, subject to the reporting person's continuous service with the issuer as of the vesting date.